Clinical Trial

Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-06-30 -> 2028-06 2026-07-19
minor Completion pushed: 2028-06-30 -> 2028-08 2026-07-19
Trial Details
NCT Number NCT06033599
Lead Sponsor Rutgers, The State University of New Jersey
Collaborators: University of Utah, National Institute on Drug Abuse (NIDA)
Conditions Polysubstance Abuse, Opioid Use, Tobacco Use
Enrollment 420 participants
Start Date 2023-09-05
Primary Completion 2028-06 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-17